The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This selective cytotoxicity facilitates immune evasion, enabling bacterial persistence and tissue invasion [104].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [104]
In the citing paper
“PVL also activates nuclear factor-kappa B (NF-κB) in neutrophils, exacerbating cytokine storms and systemic inflammation, as observed in necrotizing pneumonia and acute respiratory distress syndrome (ARDS) [104,105,113].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Self-citationVandenesch, F., Naimi, T., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M.-E., et al. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0908.030089 · Cited by 1,727
Self-citationDiep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07877-7 · Cited by 1,514 · cited 4×
“…studies, noticeably those conducted in countries with a low prevalence of CA-MRSA, PVL is associated with skin and soft tissue infections (Shallcross et al., 2013) and severe necrotizing pneumonia in otherwise healthy individuals (Gillet et al., 2002; Hidron et al., 2009; Lina et al., 1999).”
BackgroundInfluentialSelf-citationCommunity-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M., Kreiswirth, B. N., & Chambers, H. F. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,506
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira-Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Vazquez, V., Höök, M., Etienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 709
Self-citationThe chemotactic receptor for human C5a anaphylatoxin
Gerard, N. P., & Gerard, C. (1991) · Nature · doi:10.1038/349614a0 · Cited by 655
Voyich, J. M., Otto, M., Mathema, B., Braughton, K. R., Whitney, A. R., Welty, D., Long, R. D., Dorward, D. W., Gardner, D. J., Lina, G., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509506 · Cited by 565
Self-citationPoring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia
Bubeck Wardenburg, J., Bae, T., Otto, M., DeLeo, F. R., & Schneewind, O. (2007) · Nature Medicine · doi:10.1038/nm1207-1405 · Cited by 492
Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent
de Haas, C. J. C., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J. B., Heezius, E. C. J. M., Poppelier, M. J. J. G., Van Kessel, K. P. M., & van Strijp, J. A. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031636 · Cited by 471
Self-citationShallcross, L. J., Fragaszy, E., Johnson, A. M., & Hayward, A. C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70238-4 · Cited by 463
Löffler, B., Hussain, M., Grundmeier, M., Brück, M., Holzinger, D., Varga, G., Roth, J., Kahl, B. C., Proctor, R. A., & Peters, G. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000715 · Cited by 436
Function, structure and therapeutic potential of complement C5a receptors
Monk, P. N., Scola, A., Madala, P., & Fairlie, D. P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707332 · Cited by 404
Diep, B. A., Chan, L., Tattevin, P., Kajikawa, O., Martin, T. R., Basuino, L., Mai, T. T., Marbach, H., Braughton, K. R., Whitney, A. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912403107 · Cited by 347 · cited 2×
“In rabbit models of necrotizing pneumonia, PVL was recently confirmed to contribute to the severity of disease (Diep et al., 2010).”
BackgroundSelf-citationCCR5 is a receptor for Staphylococcus aureus leukotoxin ED
Alonzo III, F., Kozhaya, L., Rawlings, S. A., Reyes-Robles, T., DuMont, A. L., Myszka, D. G., Landau, N. R., Unutmaz, D., & Torres, V. J. (2013) · Nature · doi:10.1038/nature11724 · Cited by 291
Inhibiting the C5–C5a receptor axis
Woodruff, T. M., Nandakumar, K. S., & Tedesco, F. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.04.014 · Cited by 289
Staphylococcal innate immune evasion
Rooijakkers, S. H. M., van Kessel, K. P. M., & van Strijp, J. A. G. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.10.002 · Cited by 267
Self-citationKobayashi, S. D., Malachowa, N., Whitney, A. R., Braughton, K. R., Gardner, D. J., Long, D., Wardenburg, J. B., Schneewind, O., Otto, M., & DeLeo, F. R. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir441 · Cited by 266
Haviland, D. L., McCoy, R. L., Whitehead, W. T., Akama, H., Molmenti, E. P., Brown, A., Haviland, J. C., Parks, W. C., Perlmutter, D. H., & Wetsel, R. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1861 · Cited by 247
Panton, P. N., & Valentine, F. C. O. (1932) · The Lancet · doi:10.1016/s0140-6736(01)24468-7 · Cited by 243
Ventura, C. L., Malachowa, N., Hammer, C. H., Nardone, G. A., Robinson, M. A., Kobayashi, S. D., & DeLeo, F. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011634 · Cited by 204
Human genetics of infectious diseases: between proof of principle and paradigm
Alcaïs, A., Abel, L., & Casanova, J.-L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38111 · Cited by 182
Hidron, A. I., Low, C. E., Honig, E. G., & Blumberg, H. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70133-1 · Cited by 180
The Chemoattractant Receptor-like Protein C5L2 Binds the C3a des-Arg77/Acylation-stimulating Protein
Kalant, D., Cain, S. A., Maslowska, M., Sniderman, A. D., Cianflone, K., & Monk, P. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m206169200 · Cited by 175
Perret, M., Badiou, C., Lina, G., Burbaud, S., Benito, Y., Bes, M., Cottin, V., Couzon, F., Juruj, C., Dauwalder, O., et al. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01772.x · Cited by 138
Self-citationEvidence for a functional role of the second C5a receptor C5L2
Gao, H., Neff, T. A., Guo, R., Speyer, C. L., Sarma, J. V., Tomlins, S. A., Man, Y., Riedemann, N. C., Hoesel, L. M., Younkin, E. M., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3424fje · Cited by 132
Colin, D. A., Mazurier, I., Sire, S., & Finck‐Barbançon, V. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3184-3188.1994 · Cited by 122
Lipinska, U., Hermans, K., Meulemans, L., Dumitrescu, O., Badiou, C., Duchateau, L., Haesebrouck, F., Etienne, J., & Lina, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022864 · Cited by 100
Self-citationFractionation of a leucocidin from Staphylococcus aureus
Woodin, A. M. (1959) · Biochemical Journal · doi:10.1042/bj0730225 · Cited by 93
Flow Cytometric Determination of Panton-Valentine Leucocidin S Component Binding
Gauduchon, V., Werner, S., Prévost, G., Monteil, H., & Colin, D. A. (2001) · Infection and Immunity · doi:10.1128/iai.69.4.2390-2395.2001 · Cited by 91
Jayasinghe, L., & Bayley, H. (2005) · Protein Science · doi:10.1110/ps.051648505 · Cited by 87
Zivkovic, A., Sharif, O., Stich, K., Doninger, B., Biaggio, M., Colinge, J., Bilban, M., Mesteri, I., Hazemi, P., Lemmens‐Gruber, R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001665 · Cited by 86
Niemann, S., Ehrhardt, C., Medina, E., Warnking, K., Tuchscherr, L. P. N., Heitmann, V., Ludwig, S., Peters, G., & Löffler, B. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis468 · Cited by 83
Hongo, I., Baba, T., Oishi, K., Morimoto, Y., Ito, T., & Hiramatsu, K. (2009) · The Journal of Infectious Diseases · doi:10.1086/605332 · Cited by 80
Postma, B., Kleibeuker, W., Poppelier, M. J. J. G., Boonstra, M., van Kessel, K. P. M., van Strijp, J. A. G., & de Haas, C. J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412230200 · Cited by 79
Prat, C., Haas, P., Bestebroer, J., de Haas, C. J. C., van Strijp, J. A. G., & van Kessel, K. P. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801523 · Cited by 78
Analysis of the Specificity of Panton-Valentine Leucocidin and Gamma-Hemolysin F Component Binding
Meyer, F., Girardot, R., Piémont, Y., Prévost, G., & Colin, D. A. (2008) · Infection and Immunity · doi:10.1128/iai.00402-08 · Cited by 68
Kew, R. R., Peng, T., DiMartino, S. J., Madhavan, D., Weinman, S. J., Cheng, D., & Prossnitz, E. R. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.329 · Cited by 64
Haas, P., de Haas, C. J. C., Poppelier, M. J. J. G., van Kessel, K. P. M., van Strijp, J. A. G., Dijkstra, K., Scheek, R. M., Fan, H., Kruijtzer, J. A. W., Liskamp, R. M. J., et al. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.014 · Cited by 62
Self-citationGraves, S. F., Kobayashi, S. D., Braughton, K. R., Whitney, A. R., Sturdevant, D. E., Rasmussen, D. L., Kirpotina, L. N., Quinn, M. T., & DeLeo, F. R. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111575 · Cited by 62
Olsen, R. J., Kobayashi, S. D., Ayeras, A. A., Ashraf, M., Graves, S. F., Ragasa, W., Humbird, T. L., Greaver, J. L., Cantu, C., Swain, J. L., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090960 · Cited by 55
Yoong, P., & Pier, G. B. (2012) · Infection and Immunity · doi:10.1128/iai.06360-11 · Cited by 54
Bardoel, B. W., Hartsink, D., Vughs, M. M., de Haas, C. J. C., van Strijp, J. A. G., & van Kessel, K. P. M. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01765.x · Cited by 52
Cited by
Pathogenicity and virulence of Staphylococcus aureus
Cheung, G. Y. C., Bae, J. S., & Otto, M. (2021) · Virulence · doi:10.1080/21505594.2021.1878688 · Cited by 1,380
Pore-forming toxins: ancient, but never really out of fashion
Peraro, M. D., & van der Goot, F. G. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.3 · Cited by 788
Staphylococcus aureus host interactions and adaptation
Howden, B. P., Giulieri, S. G., Wong Fok Lung, T., Baines, S. L., Sharkey, L. K., Lee, J. Y. H., Hachani, A., Monk, I. R., & Stinear, T. P. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00852-y · Cited by 689
Otto, M. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.11.004 · Cited by 643
Staphylococcal manipulation of host immune responses
Thammavongsa, V., Kim, H. K., Missiakas, D., & Schneewind, O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3521 · Cited by 598
Metadata
- Authors
- Spaan, A. N., Henry, T., van Rooijen, W. J. M., Perret, M., Badiou, C., Aerts, P. C., Kemmink, J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., Lina, G., & van Strijp, J. A. G.
- Venue
- Cell Host & Microbe
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 13
- Issue
- 5
- Pages
- 584-594
- ISSN
- 1931-3128 (ISSN-L)
- OpenAlex
- W2068396700
- Cited by
- 301
- References
- 43
- FWCI
- 21.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.